Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Meier

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Der Internist|November 29, 2011
[Unclear hepatopathy in a patient with atrial fibrillation]C Pennartz, H Schrader, P R Ritter, et al.
Acta Diabetologica|January 24, 2004
A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndromeM A Nauck, J J Meier, A V Wolfersdorff, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 9, 2003
Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivityC Pox, R Ritzel, M Büsing, et al.
Diabetologia|September 7, 2007
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosisA E Butler, R Galasso, J J Meier, et al.
Diabetes, Obesity & Metabolism|June 20, 2008
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?J J Meier, B Baller, B A Menge, et al.
Diabetologia|June 28, 2006
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetesJ J Meier, J C Lin, A E Butler, et al.
Diabetes|October 27, 2001
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetesJ J Meier, K Hücking, J J Holst, et al.
Peptides|November 1, 2019
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjectsM A Nauck, H Holle, M Kahle, et al.
Regulatory Peptides|July 17, 2004
Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effectK Bulut, J J Meier, N Ansorge, et al.
Der Internist|September 3, 2017
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports]T G K Breuer, K Kampmann, A Wutzler, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Der Internist|November 29, 2011
[Unclear hepatopathy in a patient with atrial fibrillation]C Pennartz, H Schrader, P R Ritter, et al.
Acta Diabetologica|January 24, 2004
A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndromeM A Nauck, J J Meier, A V Wolfersdorff, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 9, 2003
Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivityC Pox, R Ritzel, M Büsing, et al.
Diabetologia|September 7, 2007
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosisA E Butler, R Galasso, J J Meier, et al.
Diabetes, Obesity & Metabolism|June 20, 2008
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?J J Meier, B Baller, B A Menge, et al.
Diabetologia|June 28, 2006
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetesJ J Meier, J C Lin, A E Butler, et al.
Diabetes|October 27, 2001
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetesJ J Meier, K Hücking, J J Holst, et al.
Peptides|November 1, 2019
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjectsM A Nauck, H Holle, M Kahle, et al.
Regulatory Peptides|July 17, 2004
Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effectK Bulut, J J Meier, N Ansorge, et al.
Der Internist|September 3, 2017
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports]T G K Breuer, K Kampmann, A Wutzler, et al.
Pageof 5